Podcast episode 36 (in German)

The Wolverine Stack: BPC-157 + TB-500 – the regeneration duo

August 10, 2026

Named after the comic hero who heals himself in seconds: the Wolverine Stack combines BPC-157 and TB-500, two peptides that act at different points of healing. The episode explains why the combination seems so coherent and where the data stop.

What it is about

BPC-157 is derived from a protective substance in gastric juice; the name stands for “Body Protection Compound”. It stimulates the formation of new blood vessels and the build-up of connective tissue and has a particular reputation for poorly perfused tissues such as tendons and ligaments, as well as for the gut. TB-500 is the synthetic version of thymosin beta-4; it regulates the cell protein actin, makes repair cells more mobile and dampens inflammation. Using a strained tendon as an example, the episode plays through how the two work together via separate signaling pathways in different phases of healing. What remains is a mechanistically elegant concept with strong animal data, but without large studies in humans.

Key points

BPC-157 promotes angiogenesis, the formation of new blood vessels; more vessels mean more oxygen and nutrients for repair, especially in tendons, ligaments and the gut.
As a derivative of thymosin beta-4, TB-500 regulates the protein actin; repair cells therefore migrate more easily to the site of damage, and it also dampens inflammation.
In the first phase of healing, TB-500 dampens excessive inflammation; in the weeks that follow, BPC-157 drives new vessel formation and collagen build-up; the pathways do not overlap.
In injured tissue, BPC-157 appears to amplify the signaling pathways of growth hormone, making repair cells more receptive to the body’s own healing signals.
The body’s own thymosin beta-4, the model for TB-500, also plays a role in healing of the heart and of the cornea of the eye.
As a report: users employ the stack mainly for stubborn injuries of tendons, ligaments and muscles and describe better mobility and less stiffness.
BPC-157 and TB-500 are on the World Anti-Doping Agency’s prohibited list and, as of August 2026, are not approved as medicines either in the US or in Germany.

Where the data stop

For both peptides there are many animal data on wound healing, new vessel formation and tissue regeneration; the mechanism is well described. Large studies in humans are missing, and all the more so for the combination: the synergy is mechanistically coherent but not clinically proven. Long-term safety is also open. The many enthusiastic personal accounts are reports, not measurements.

As gray-market products, their purity and quality depend on the supplier; in competitive sport both peptides are off-limits. For healthy recreational athletes without an injury the benefit is unclear; for them, sleep, protein and sensible load management achieve more. Anyone with a stubborn injury should discuss it with a physician.

Listen (in German)

Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music

Published on August 10, 2026.

The topic in the database

The popular “repair peptide” – the regenerative effects on tendons, connective tissue and gastrointestinal mucosa come from animal experiments. Controlled…BPC-157

All episodes in the app (German)

Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.